Chemical Compound

Frovatriptan succinate

CAS Registry Number 158930-17-7
Frovatriptan succinate chemical structure
Primary Record

Frovatriptan succinate

Note: Only for scientific research or as raw materials for production.

In stock
7,189 g
Purity
99.6 %
CAS
158930-17-7

Compound Identifiers & Properties

CAS
158930-17-7
PubChem CID
152943
SMILES
CN[C@@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N.C(CC(=O)O)C(=O)O.O
Canonical SMILES
CN[C@@H]1CCc2[nH]c3ccc(C(N)=O)cc3c2C1.O.O=C(O)CCC(=O)O

Names & Synonyms

  • Frovatriptan succinate
  • Frova
  • Frovelan
  • Migard
  • Frovatriptan
  • Frovatriptan succinate hydrate
  • Miguard
  • Frovatriptan Succinate monohydrate
  • 158930-17-7
  • Frovatriptan succinate [USAN]
  • Frova (TN)
  • Frovatriptan (succinate hydrate)
  • RefChem:56376
  • VML 251
  • VML-251
  • D28J6W18HY
  • UNII-D28J6W18HY
  • SB-209509ax
  • DTXSID2049056
  • AC1L49EG
  • SB 209509-AX
  • DTXCID7028982
  • Frovatriptan succinate (USAN)
  • SB 209509 AX
  • SB-209509-AX
  • HY-B1658AR
  • orb1309659
  • SCHEMBL2321442
  • VML251
  • CHEMBL2138684
  • DTXCID8089034
  • NSC-760422
  • CTK4C9886
  • HY-B1658A
  • DTXSID90166543
  • Frovatriptan succinate monihydrate
  • CUETXFMONOSVJA-KLQYNRQASA-N
  • MFCD18251278
  • 36K05YF32G
  • C14H17N3O.C4H6O4.H2O
  • C18H25N3O6
  • GLXC-04981
  • IGA93017
  • Tox21_113606
  • CID152943
  • EBC-76033
  • NCGC00183880-01
  • AKOS030241886
  • FROVATRIPTAN SUCCINATE [MART.]
  • FROVATRIPTAN SUCCINATE [USP-RS]
  • NSC 760422
  • MS-26200
  • Frovatriptan (succinate hydrate) (Standard)
  • FROVATRIPTAN SUCCINATE [ORANGE BOOK]
  • LS-173538
  • CAS-158930-17-7
  • CS-0021309
  • C14-H17-N3-O.C4-H6-O4.H2-O
  • D04264
  • FROVATRIPTAN SUCCINATE MONOHYDRATE [MI]
  • G13944
  • Butanedioic acid, compd. with (R)-2,3,4,9-tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide, hydrate (1:1:1)
  • A950323
  • FROVATRIPTAN SUCCINATE MONOHYDRATE [WHO-DD]
  • Frovatriptan succinate monohydrate, >=97% (HPLC)
  • (+)-(R)-5,6,7,8-Tetrahydro-6-(methylamino)carbazole-3-carboxamide succinate (1:1), monohydrate
  • butanedioic acid;(6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide;hydrate
  • Q27276007
  • Butanedioic acid, compd. with (R)-2,3,4,9-tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide (1:1), monohydrate
  • (R)-3-(Methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide succinate hydrate
  • (+)-(R)-2,3,4,9-Tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide butanedioate (1:1), monohydrate
  • butanedioic acid,(6R)-6-methylamino-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide;hydrate
  • 1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (R)-, butanedioate (1:1), monohydrate
  • Frovatriptan succinate, United States Pharmacopeia (USP) Reference Standard
  • (3R)-2,3,4,9-Tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide butanedioate
  • (6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide succinate monohydrate
  • (6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide;succinic acid;hydrate
  • 1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-,(3R)-, Butanedioate(1:1)
  • (3R)-2,3,4,9-Tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide Butanedioic Acid Monohydrate
  • 158747-02-5
  • 158930-09-7
  • Butanedioic acid, compd. with (3R)-2,3,4,9-tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide (1:1)
  • butanedioic acid,(6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide,hydrate
  • Butanedioic acid--(3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide--water (1/1/1)
  • butanedioic acid; (6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide; hydrate
  • Frovatriptan Succinate Monohydrate; Butanedioic acid, compd. with (R)-2,3,4,9-tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide, hydrate (1:1:1); Butanedioic acid, compd. with (R)-2,3,4,9-tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide (1:1), monohydrate (9CI); 1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (R)-, butanedioate (1:1), monohydrate (9CI); Frovatriptan succinate hydrate